Trial · NCT03070600
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Maternal HIV Incidence | 6 weeks, 6 months, 9 months postpartum | incidence/100 Person years | NUMBER | |
| PRIMARY | Appropriate PrEP Decision | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | PrEP Adherence | Enrollment to 9 months postpartum | Of the 186 participants sampled for this analyses, 427 DBS samples were analyzed (232 universal arm, 195 targeted arm). | Samples w/ adherence at ~7dose/week | NUMBER |
| SECONDARY | PrEP Duration | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | This analysis is restricted to participants who initiated PrEP during the study period. | months | MEDIAN |
| SECONDARY | Partner With Known HIV Status | At 9 months postpartum | This analysis is restricted to participants who reported having a partner at 9-months postpartum. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Infant Birthweight | time of delivery | This analysis is restricted to mothers with live born infants with birth weight data available in their clinical records. | kg | MEDIAN |
| SECONDARY | Infant Growth | 9 months of age | Length measurements could not be ascertained from all infants | z-score | MEDIAN |
| SECONDARY | PrEP Use | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | PrEP Acceptance | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Preterm Birth | At birth | This analysis is restricted to participants who reported a live birth and had gestational age at birth data available. | Participants | COUNT_OF_PARTICIPANTS |
| OTHER_PRE_SPECIFIED | PrEP Adherence by Self-report | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Partner on ART if HIV Positive | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | This analysis is restricted to participants with a partner known to be living with HIV. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03070600/outcomes